Th. Duka

564 total citations
20 papers, 432 citations indexed

About

Th. Duka is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Th. Duka has authored 20 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 10 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Th. Duka's work include Neuropeptides and Animal Physiology (7 papers), Receptor Mechanisms and Signaling (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Th. Duka is often cited by papers focused on Neuropeptides and Animal Physiology (7 papers), Receptor Mechanisms and Signaling (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Th. Duka collaborates with scholars based in Germany, Switzerland and Ireland. Th. Duka's co-authors include A. Herz, A. Doenicke, Margret R. Hoehe, R. Dorow, Michael Wüster, Peter Schubert, R. Cumin, W. Haefely, Manfred Ackenheil and I. Haarmann and has published in prestigious journals such as Brain Research, Cellular and Molecular Life Sciences and Psychopharmacology.

In The Last Decade

Th. Duka

20 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Th. Duka Germany 11 268 171 80 71 57 20 432
R. Dorow Germany 14 300 1.1× 147 0.9× 184 2.3× 29 0.4× 36 0.6× 34 647
Gad Klein United States 13 241 0.9× 137 0.8× 85 1.1× 190 2.7× 31 0.5× 13 462
R. J. NAYLOR United Kingdom 10 164 0.6× 102 0.6× 52 0.7× 41 0.6× 41 0.7× 21 422
Kathleen A. Haberny United States 6 229 0.9× 101 0.6× 32 0.4× 76 1.1× 27 0.5× 8 356
Nathalie Dourmap France 15 323 1.2× 234 1.4× 67 0.8× 97 1.4× 18 0.3× 31 571
N. Zonta Italy 13 312 1.2× 141 0.8× 54 0.7× 299 4.2× 46 0.8× 22 480
I.H. Ayhan Türkiye 12 349 1.3× 133 0.8× 51 0.6× 139 2.0× 22 0.4× 24 558
B.A. Chizh United Kingdom 10 203 0.8× 161 0.9× 67 0.8× 267 3.8× 63 1.1× 19 586
J.W. Lewis United States 10 211 0.8× 188 1.1× 36 0.5× 168 2.4× 13 0.2× 15 385
Hj. Teschemacher Germany 8 327 1.2× 163 1.0× 48 0.6× 274 3.9× 48 0.8× 9 481

Countries citing papers authored by Th. Duka

Since Specialization
Citations

This map shows the geographic impact of Th. Duka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Th. Duka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Th. Duka more than expected).

Fields of papers citing papers by Th. Duka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Th. Duka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Th. Duka. The network helps show where Th. Duka may publish in the future.

Co-authorship network of co-authors of Th. Duka

This figure shows the co-authorship network connecting the top 25 collaborators of Th. Duka. A scholar is included among the top collaborators of Th. Duka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Th. Duka. Th. Duka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Millan, Mark J. & Th. Duka. (2015). Anxiolytic Properties of Opiates and Endogenous Opioid Peptides and Their Relationship to the Actions of Benzodiazepines1. PubMed. 17. 123–141. 3 indexed citations
2.
Hoehe, Margret R. & Th. Duka. (1993). Opiates increase plasma catecholamines in humans. Psychoneuroendocrinology. 18(2). 141–148. 23 indexed citations
3.
Duka, Th., et al.. (1993). Abecarnil: A New ß-Carboline Anxiolytic Preliminary Clinical Pharmacology. PubMed. 11. 132–147. 3 indexed citations
4.
Kŕause, W., et al.. (1991). The pharmacokinetics and pharmacodynamics of lisuride in healthy volunteers after intravenous, intramuscular, and subcutaneous injection. European Journal of Clinical Pharmacology. 40(4). 399–403. 2 indexed citations
5.
Kŕause, W., et al.. (1991). Pharmacokinetics and biotransformation of the anxiolytic abecarnil in healthy volunteers. Xenobiotica. 21(6). 763–774. 3 indexed citations
6.
Kŕause, W., et al.. (1990). Pharmacokinetics and acute toleration of the beta-carboline derivative abecarnil in man.. PubMed. 40(5). 529–32. 10 indexed citations
7.
Hoehe, Margret R., Th. Duka, & A. Doenicke. (1988). Human studies on the μ opiate receptor agonist fentanyl: Neuroendocrine and behavioral responses. Psychoneuroendocrinology. 13(5). 397–408. 34 indexed citations
8.
Duka, Th., et al.. (1988). [Benzodiazepine antagonism by RO 15-1788: psychometric, hormonal and biophysical parameters].. PubMed. 37(8). 535–42. 4 indexed citations
9.
Duka, Th., Margret R. Hoehe, A. Doenicke, U Stephan, & N. Matussek. (1987). Influence of the histaminergic system on opiate-induced neurosecretion and behaviour. Psychoneuroendocrinology. 12(4). 271–280. 5 indexed citations
10.
Dorow, R., et al.. (1987). β-Carbolines: New Insights into the Clinical Pharmacology of Benzodiazepine Receptor Ligands. PubMed. 3. 37–51. 13 indexed citations
11.
Stephens, D.N., W. Kehr, & Th. Duka. (1986). Anxiolytic and anxiogenic beta-carbolines: tools for the study of anxiety mechanisms.. PubMed. 41. 91–106. 10 indexed citations
12.
13.
Doenicke, Α., W Lorenz, D.R. Stanworth, Th. Duka, & J. B. Glen. (1985). Effects of propofol ('Diprivan') on histamine release, immunoglobulin levels and activation of complement in healthy volunteers.. PubMed. 61 Suppl 3. 15–20. 33 indexed citations
14.
Klotz, Ulrich, Th. Duka, R. Dorow, & A. Doenicke. (1985). Flunitrazepam and lormetazepam do not affect the pharmacokinetics of the benzodiazepine antagonist Ro 15‐1788.. British Journal of Clinical Pharmacology. 19(1). 95–98. 28 indexed citations
15.
Hoehe, Margret R., Th. Duka, A. Doenicke, & N. Matussek. (1984). Dose-dependent influence of Fentanyl on prolactin, growth hormone, and mood. Neuropeptides. 5(1-3). 269–272. 7 indexed citations
16.
Duka, Th., et al.. (1981). A selective distribution pattern of different opiate receptors in certain areas of rat brain as revealed by in vitro autoradiography. Neuroscience Letters. 21(2). 119–124. 80 indexed citations
17.
Duka, Th., E. P. Bonetti, Gianpietro Bondiolotti, & Michael Wüster. (1981). Naloxone reduces abdominal muscle tone in mice and rats. Cellular and Molecular Life Sciences. 37(8). 881–882. 2 indexed citations
18.
Duka, Th., R. Cumin, W. Haefely, & A. Herz. (1981). Naloxone blocks the effect of diazepam and meprobamate on conflict behaviour in rats. Pharmacology Biochemistry and Behavior. 15(1). 115–117. 59 indexed citations
19.
Herz, A., Th. Duka, C. Gramsch, et al.. (1980). Pharmacologic manipulation of brain and pituitary endorphin content and release.. PubMed. 22. 323–33. 3 indexed citations
20.
Przewłocki, Ryszard, Th. Duka, G. Kleber, et al.. (1979). Long-term morphine treatment decreases endorphin levels in rat brain and pituitary. Brain Research. 174(2). 357–361. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Dorow Breakdown of academic impact, for papers by Gad Klein Breakdown of academic impact, for papers by R. J. NAYLOR Breakdown of academic impact, for papers by Kathleen A. Haberny Breakdown of academic impact, for papers by Nathalie Dourmap Breakdown of academic impact, for papers by N. Zonta Breakdown of academic impact, for papers by I.H. Ayhan Breakdown of academic impact, for papers by B.A. Chizh Breakdown of academic impact, for papers by J.W. Lewis Breakdown of academic impact, for papers by Hj. Teschemacher
Rankless by CCL
2026